Cost implications of implementation of pathogen-inactivated platelets.
McCullough J, Goldfinger D, Gorlin J, Riley WJ, Sandhu H, Stowell C, Ward D, Clay M, Pulkrabek S, Chrebtow V, Stassinopoulos A.
McCullough J, et al.
Transfusion. 2015 Oct;55(10):2312-20. doi: 10.1111/trf.13149. Epub 2015 May 18.
Transfusion. 2015.
PMID: 25989465
Free PMC article.